For the quarter ending 2026-03-31, ADTX made $12,159 in revenue. -$15,947,725 in net income. Net profit margin of -131159.84%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Sales | 12,159 | 425 | 748 | 1,004 |
| Cost of goods sold | 9,291 | 456 | 732 | 1,005 |
| Gross profit | 2,868 | -31 | 16 | -1 |
| Sales and marketing 473,311 and 0 in stock-based compensation, respectively | - | -3,995 | 6,040 | 349,031 |
| General and administrative expenses 0 and 0 in stock-based compensation, respectively | 3,317,648 | 4,124,992 | 2,462,561 | 5,039,036 |
| Research and development 0 and 10,000 in stock-based compensation, respectively | 1,047,083 | 548,556 | 672,045 | 764,327 |
| Total operating expenses | 4,364,731 | 4,669,553 | 3,140,646 | 6,152,394 |
| Net loss from operations | -4,361,863 | -4,669,584 | -3,140,630 | -6,152,395 |
| Interest expense | 27,136 | 299,778 | 176,527 | 47,352 |
| Interest income | 280 | -62,306 | 183,631 | 78,566 |
| Amortization of debt discount | 24,687 | 60,000 | 234,167 | 1,212,246 |
| Gain (loss) on note exchange agreement | - | - | - | 0 |
| Change in fair value of derivative liabilities | 11,800,798 | -228 | -162 | -980 |
| Change in fair value of evofem warrants | -25,004 | 865,872* | -2,511,781 | 63,211 |
| Impairment of evofem f-1 preferred stock | - | -747,044.5* | 23,001,919 | - |
| Bargain purchase gain from purchase of evofem convertible notes | - | -82,017.75* | - | - |
| Credit loss on evofem notes | - | - | 350,000 | - |
| Impairment of fixed assets | - | 103,001.25* | - | - |
| Total other expense | -11,827,337 | -561,667 | -21,067,039 | -1,243,263 |
| Net loss before income taxes | -16,189,200 | -5,231,251 | -24,207,669 | -7,395,658 |
| Income tax provision | - | - | - | 0 |
| Net loss | -16,189,200 | -5,231,251 | -24,207,669 | -7,395,658 |
| Deemed dividends | - | -1,387,250 | - | - |
| Net loss attributable to non-controlling interest | -241,475 | -529,572 | -162,264 | -138,850 |
| Net loss attributable to aditxt, inc. & subsidiaries | -15,947,725 | -6,088,929 | -24,045,405 | -7,256,808 |
| Basic EPS | -790.49 | -163.002 | -548.78 | -3.45 |
| Diluted EPS | -790.49 | -163.002 | -548.78 | -3.45 |
| Basic Average Shares | 20,174 | 37,355* | 43,816 | 2,101,701 |
| Diluted Average Shares | 20,174 | 37,355* | 43,816 | 2,101,701 |
Aditxt, Inc. (ADTX)
Aditxt, Inc. (ADTX)